BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33276029)

  • 1. Assessing the role of amino acids in systemic inflammation and organ failure in patients with ACLF.
    Zaccherini G; Aguilar F; Caraceni P; Clària J; Lozano JJ; Fenaille F; Castelli F; Junot C; Curto A; Formentin C; Weiss E; Bernardi M; Jalan R; Angeli P; Moreau R; Arroyo V
    J Hepatol; 2021 May; 74(5):1117-1131. PubMed ID: 33276029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF.
    Moreau R; Clària J; Aguilar F; Fenaille F; Lozano JJ; Junot C; Colsch B; Caraceni P; Trebicka J; Pavesi M; Alessandria C; Nevens F; Saliba F; Welzel TM; Albillos A; Gustot T; Fernández J; Moreno C; Baldassarre M; Zaccherini G; Piano S; Montagnese S; Vargas V; Genescà J; Solà E; Bernal W; Butin N; Hautbergue T; Cholet S; Castelli F; Jansen C; Steib C; Campion D; Mookerjee R; Rodríguez-Gandía M; Soriano G; Durand F; Benten D; Bañares R; Stauber RE; Gronbaek H; Coenraad MJ; Ginès P; Gerbes A; Jalan R; Bernardi M; Arroyo V; Angeli P; ; ;
    J Hepatol; 2020 Apr; 72(4):688-701. PubMed ID: 31778751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis.
    Sundaram V; Jalan R; Ahn JC; Charlton MR; Goldberg DS; Karvellas CJ; Noureddin M; Wong RJ
    J Hepatol; 2018 Sep; 69(3):617-625. PubMed ID: 29709681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.
    Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Janicko M; Steib C; Reiberger T; Acevedo J; Gatti P; Bernal W; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Bendtsen F; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solè C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Özdogan OC; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Curto A; Pitarch C; Putignano A; Moreno E; Shawcross D; Aguilar F; Clària J; Ponzo P; Jansen C; Vitalis Z; Zaccherini G; Balogh B; Vargas V; Montagnese S; Alessandria C; Bernardi M; Ginès P; Jalan R; Moreau R; Angeli P; Arroyo V;
    J Hepatol; 2020 Oct; 73(4):842-854. PubMed ID: 32673741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis.
    López-Vicario C; Checa A; Urdangarin A; Aguilar F; Alcaraz-Quiles J; Caraceni P; Amorós A; Pavesi M; Gómez-Cabrero D; Trebicka J; Oettl K; Moreau R; Planell N; Arroyo V; Wheelock CE; Clària J
    J Hepatol; 2020 Oct; 73(4):817-828. PubMed ID: 32294533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis.
    Trebicka J; Amoros A; Pitarch C; Titos E; Alcaraz-Quiles J; Schierwagen R; Deulofeu C; Fernandez-Gomez J; Piano S; Caraceni P; Oettl K; Sola E; Laleman W; McNaughtan J; Mookerjee RP; Coenraad MJ; Welzel T; Steib C; Garcia R; Gustot T; Rodriguez Gandia MA; Bañares R; Albillos A; Zeuzem S; Vargas V; Saliba F; Nevens F; Alessandria C; de Gottardi A; Zoller H; Ginès P; Sauerbruch T; Gerbes A; Stauber RE; Bernardi M; Angeli P; Pavesi M; Moreau R; Clària J; Jalan R; Arroyo V
    Front Immunol; 2019; 10():476. PubMed ID: 30941129
    [No Abstract]   [Full Text] [Related]  

  • 7. The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis.
    Arroyo V; Angeli P; Moreau R; Jalan R; Clària J; Trebicka J; Fernández J; Gustot T; Caraceni P; Bernardi M;
    J Hepatol; 2021 Mar; 74(3):670-685. PubMed ID: 33301825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction governs immunometabolism in leukocytes of patients with acute-on-chronic liver failure.
    Zhang IW; Curto A; López-Vicario C; Casulleras M; Duran-Güell M; Flores-Costa R; Colsch B; Aguilar F; Aransay AM; Lozano JJ; Hernández-Tejero M; Toapanta D; Fernández J; Arroyo V; Clària J
    J Hepatol; 2022 Jan; 76(1):93-106. PubMed ID: 34450236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell death markers in patients with cirrhosis and acute decompensation.
    Macdonald S; Andreola F; Bachtiger P; Amoros A; Pavesi M; Mookerjee R; Zheng YB; Gronbaek H; Gerbes AL; Sola E; Caraceni P; Moreau R; Gines P; Arroyo V; Jalan R
    Hepatology; 2018 Mar; 67(3):989-1002. PubMed ID: 29023872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis.
    Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jansen C; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Jarcuska P; Steib C; Reiberger T; Acevedo J; Gatti P; Shawcross DL; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Danielsen KV; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solé C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Kani HT; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia-Lopez E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Praktiknjo M; Curto A; Pitarch C; Putignano A; Moreno E; Bernal W; Aguilar F; Clària J; Ponzo P; Vitalis Z; Zaccherini G; Balogh B; Gerbes A; Vargas V; Alessandria C; Bernardi M; Ginès P; Moreau R; Angeli P; Jalan R; Arroyo V;
    J Hepatol; 2021 May; 74(5):1097-1108. PubMed ID: 33227350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Acute-on-Chronic Liver Failure Syndrome, or When the Innate Immune System Goes Astray.
    Clària J; Arroyo V; Moreau R
    J Immunol; 2016 Nov; 197(10):3755-3761. PubMed ID: 27815438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in Cirrhosis.
    Clària J; Moreau R; Fenaille F; Amorós A; Junot C; Gronbaek H; Coenraad MJ; Pruvost A; Ghettas A; Chu-Van E; López-Vicario C; Oettl K; Caraceni P; Alessandria C; Trebicka J; Pavesi M; Deulofeu C; Albillos A; Gustot T; Welzel TM; Fernández J; Stauber RE; Saliba F; Butin N; Colsch B; Moreno C; Durand F; Nevens F; Bañares R; Benten D; Ginès P; Gerbes A; Jalan R; Angeli P; Bernardi M; Arroyo V;
    Hepatology; 2019 Apr; 69(4):1686-1701. PubMed ID: 30521097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and prognosis of acute on chronic liver failure (ACLF) in cirrhosis.
    Arroyo V; Moreau R
    J Hepatol; 2017 Feb; 66(2):451-453. PubMed ID: 27989380
    [No Abstract]   [Full Text] [Related]  

  • 14. Dysregulated Adaptive Immunity Is an Early Event in Liver Cirrhosis Preceding Acute-on-Chronic Liver Failure.
    Rueschenbaum S; Ciesek S; Queck A; Widera M; Schwarzkopf K; Brüne B; Welsch C; Wedemeyer H; Zeuzem S; Weigert A; Lange CM
    Front Immunol; 2020; 11():534731. PubMed ID: 33574809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vulnerability to recurrent episodes of acute decompensation/acute-on-chronic liver failure characterizes those triggered by indeterminate precipitants in patients with liver cirrhosis.
    Hoshi H; Chu PS; Yoshida A; Taniki N; Morikawa R; Yamataka K; Noguchi F; Kasuga R; Tabuchi T; Ebinuma H; Saito H; Kanai T; Nakamoto N
    PLoS One; 2021; 16(4):e0250062. PubMed ID: 33848309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol-related acute-on-chronic liver failure.
    Mehta G; Mookerjee RP; Sharma V; Jalan R
    Liver Int; 2015 Mar; 35(3):724-34. PubMed ID: 24703488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure.
    Clària J; Stauber RE; Coenraad MJ; Moreau R; Jalan R; Pavesi M; Amorós À; Titos E; Alcaraz-Quiles J; Oettl K; Morales-Ruiz M; Angeli P; Domenicali M; Alessandria C; Gerbes A; Wendon J; Nevens F; Trebicka J; Laleman W; Saliba F; Welzel TM; Albillos A; Gustot T; Benten D; Durand F; Ginès P; Bernardi M; Arroyo V;
    Hepatology; 2016 Oct; 64(4):1249-64. PubMed ID: 27483394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.
    Moreau R; Jalan R; Gines P; Pavesi M; Angeli P; Cordoba J; Durand F; Gustot T; Saliba F; Domenicali M; Gerbes A; Wendon J; Alessandria C; Laleman W; Zeuzem S; Trebicka J; Bernardi M; Arroyo V;
    Gastroenterology; 2013 Jun; 144(7):1426-37, 1437.e1-9. PubMed ID: 23474284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocytes, Systemic Inflammation and Immunopathology in Acute-on-Chronic Liver Failure.
    Casulleras M; Zhang IW; López-Vicario C; Clària J
    Cells; 2020 Dec; 9(12):. PubMed ID: 33302342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF).
    Grønbæk H; Rødgaard-Hansen S; Aagaard NK; Arroyo V; Moestrup SK; Garcia E; Solà E; Domenicali M; Piano S; Vilstrup H; Møller HJ;
    J Hepatol; 2016 Apr; 64(4):813-22. PubMed ID: 26639396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.